We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
• You should state whether an appropriate sample size was computed when the study was being designed • You should state the statistical method of sample size computation and any required assumptions • If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates
• You should report how often each experiment was performed
• You should include a definition of biological versus technical replication • The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates • If you encountered any outliers, you should describe how these were handled • Criteria for exclusion/inclusion of data should be clearly stated • High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
Sample size for each experiment is described in the methods or in the figures' captions. While sample sizes used in this study were not pre-determined by statistical means, they are similar to the standard practice within the field.
As reported in the Methods section, Experiment 2 was performed twice. It was performed in two independent cohorts of rats, each receiving intracranial injection of a viral vector obtained from a different source (i.e., UNC Chapel Hill vs. Addgene). Experiments 1, 3, and 4 were each conducted once, as stated in the methods. Exclusion of individuals was based only on histological verification of viral expression or cannula placement. Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation
• Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied • Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data")
• We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table • Where provided, these should be in the most useful format, and they can be uploaded as "Source data" files linked to a main figure or table • Include model definition files including the full list of parameters used • Include code used for data analysis (e.g., R, MatLab)
• Avoid stating that data files are "available upon request" Please indicate the figures or tables for which source data files have been provided: Statistical analyses are described in details in the "Statistical Analysis" paragraph in the Methods section. Details about the methods of measures (e.g., mean, SEM) are stated in the captions of each figure.
Exact p values are reported in the results and statistical tables included in supplementary information.
Rats were randomly assigned to the different viral vector groups (hM4di vs. mCherry) or cannula localization groups (NAc vs. mPFC) ahead of surgery. Experimenters were not blinded for data collection and analysis.
